Direct comparison
K08 vs. K23 NIH Career Awards Compared
K08 vs. K23: both fund clinical career development, but K23 requires patient-oriented research and K08 does not. Compare eligibility, review, and budgets.
Ask about K08 vs. K23 NIH Career Awards Compared
Answers are drawn from this comparison and the rest of the CASRAI corpus, with a link to every source.
Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this
How do K08, K23 compare side by side?
The table below compares K08, K23 across 10 procurement-relevant dimensions, from full name through ic participation.
Side-by-side comparison
| Dimension | K08 | K23 |
|---|---|---|
| Full name | Mentored Clinical Scientist Research Career Development Award | Mentored Patient-Oriented Research Career Development Award |
| Research focus | Basic, mechanistic, or laboratory-based research that is not patient-oriented | Patient-oriented research — direct interaction with human subjects or identifiable human-derived material; can combine with laboratory work |
| Typical applicant | Physician-scientist (or equivalent clinical doctorate) pursuing independent bench/mechanistic research | Physician-scientist (or equivalent) pursuing independent clinical, translational, or outcomes research involving patients |
| Eligible degree | Clinical doctoral degree (e.g. MD, DO, or equivalent) | Health-professional doctoral degree — explicitly includes MD, DO, DDS, DMD, OD, DC, PharmD, ND, and non-clinical PhD holders certified to perform clinical duties |
| Mentor requirement | Required — typically an independently NIH-funded investigator with prior K-mentoring experience | Required — same standard as K08 |
| Protected effort | Typically ≥ 75% (9 calendar months) of full-time professional effort | Typically ≥ 75% (9 calendar months) of full-time professional effort |
| Review criteria | Five K-specific criteria: Candidate, Career Development Plan, Research Plan, Mentor, Environment | Same five K-specific criteria as K08 |
| Budget structure | IC-specific capped salary support plus a separate itemized research allowance | Same structure as K08; caps and allowances set per awarding IC |
| Typical duration | 3–5 years, generally non-renewable | 3–5 years, generally non-renewable |
| IC participation | Widely funded across NIH Institutes and Centers | Funded by most, but not all, ICs — e.g. NCI discontinued its K23 program in 2018 |
Common questions
Common questions about K08 vs K23
Can a K08 candidate's research use human-derived tissue?
+
Yes, as long as the work cannot be linked back to an identifiable patient. Research using de-identified human tissue that does not require direct interaction with human subjects or identifiable patient data falls under K08, not K23. The moment the research requires identifiable patient linkage or direct human-subject interaction, it becomes patient-oriented research and the K23 mechanism applies instead.
Can K23 research include laboratory work?
+
Yes. K23 explicitly allows a combination of patient-oriented and laboratory research, as long as the patient-oriented component is a genuine part of the research plan — it does not need to be exclusively clinical.
Do K08 and K23 have different funding amounts?
+
No formal difference in structure: both use IC-specific, capped salary support plus a separate itemized research-support allowance, and both are reviewed against the same budget expectations. The exact cap depends on the awarding Institute or Center and current fiscal year parameters, not on which of the two mechanisms is used.
Does every NIH institute fund both K08 and K23?
+
No. IC participation varies and changes over time — for example, NCI discontinued its K23 program in 2018 and redirects patient-oriented-research candidates toward K08, K12, and K99/R00 instead. Always confirm current participation on the specific awarding IC's own K-award program page before building an application around either mechanism.
Is one mechanism more competitive than the other?
+
NIH does not publish a standing claim that either mechanism is systematically more or less competitive; success rates vary by awarding IC, fiscal year, and applicant pool. The mechanism choice should be driven by the research type (patient-oriented vs. not), not by an assumption about relative competitiveness.
